Professional Documents
Culture Documents
Combination of Propofol and Remifentanil TCI For LMA2012
Combination of Propofol and Remifentanil TCI For LMA2012
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol It has been determined the optimal dose of Remifentanil required for the successful insertion of Streamlined Liner of the Pharynx Airway (SLIPA) and to compare it to that required for LMA insertion in patients receiving a Propofol infusion at a standard effect-site concentration.
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
58 patients scheduled to undergo GA were randomly assigned to either: The SLIPA (n = 29) group or LMA (n = 29) group.
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
Premedication: Midazolam 0.05 mg x kg(-1) and Glycopyrrolate 0.004 mg x kg(-1) IM.
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
GA: Lignocaine 1 mg/ kg IV;
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
The Remifentanil dose: 4 ng/ml. 6 min. after induction, the airway device was inserted.
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
Airway device insertion was classified as 'success' or 'failure' based on patient response.
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
The EC50 of Remifentanil for SLIPA and LMA were: 0.93 ng x ml(-1) (95% confidence interval [CI] 0.81 to 1.50 ng x ml(-1) and
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
The EC95 for SLIPA and LMA insertions were: 1.90 ng x ml(-1) (95% CI 1.39 to 1.95) and
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
EC50 for SLIPA was significantly less than that of LMA: 0.83 to 1.23 vs 1.26 to 2.00; (P < 0.05).
Comparison of the effect-site concentrations of Remifentanil for SLIPA vs. LMA SoftSealTM insertion during TCI of Propofol
The insertion of SLIPA needs about a 32% lower depth of anaesthesia than LMA insertion.
REFERENCES:
Kim HS, Park HJ, Kim CS, Lee JR. Combination of propofol and remifentanil targetcontrolled infusion for laryngeal mask airway insertion in children. Minerva Anestesiol. 2011 Jul;77(7):687-92. Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Korea.
REFERENCES:
Kim SH, Choi EM, Chang CH, Kim HK, Chung MH, Choi YR. Comparison of the effect-site concentrations of remifentanil for Streamlined Liner of the Pharynx Airway (SLIPA) versus laryngeal mask airway SoftSealTM insertion during target-controlled infusion of propofol. Anaesth Intensive Care. 2011 Jul;39(4):611-7. Department of Anesthesiology and Pain Medicine, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.
REFERENCES:
Minardi C, Astuto M, Taranto V, Gullo C, Gullo A. 936-7. Combination of propofol and remifentanil targetcontrolled infusion for laryngeal mask airway insertion in children: some remarks. Minerva Anestesiol. 2011 Sep;77(9):934-5; author reply 936-7. Comment on:Combination of propofol and remifentanil target-controlled infusion for laryngeal mask airway insertion in children. [Minerva Anestesiol. 2011] PMID: 21878876 [PubMed - indexed for MEDLINE] Free full text
REFERENCES:
Kim MK, Lee JW, Jang DJ, Shin OY, Nam SB. Effect-site concentration of remifentanil for laryngeal mask airway insertion during target-controlled infusion of propofol. Anaesthesia. 2009 Feb;64(2):136-40. Department of Anaesthesiology and Pain Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.